Advances in traditional Chinese and Western medicine for chronic fatigue syndrome: Theoretical origins, modern mechanisms, and clinical intervention strategies
LI Jixin, WANG Wenru, QIU Linjie, REN Yan, LI Meijie, ZOU Chacha, WU Zijing, WANG Peili, ZHANG Jin
Chronic fatigue syndrome (CFS) is characterized by persistent fatigue as its core symptom, often accompanied by cognitive impairment, pain, sleep disturbances, and emotional abnormalities. Its pathophysiology involves the interplay of multiple factors including genetics, infection, dysbiosis, immune-inflammatory dysregulation, oxidative stress, and metabolic abnormalities. Clinically, the lack of specific diagnostic markers and effective treatment options have made CFS a significant public health challenge. Traditional Chinese medicine (TCM) classifies it under the categories of “consumptive disease” and “deficiency syndrome”. The core pathogenesis is attributed to dual deficiency of the spleen and kidney, leading to impaired qi transformation. Spleen deficiency results in inadequate transportation and transformation, causing deficiency of qi and blood, which in turn fails to nourish the limbs, leading to fatigue. Kidney deficiency manifests as depletion of essence and marrow, resulting in exhaustion of primordial energy, causing mental fatigue and weakness of tendons and bones. Mutual impairment of spleen and kidney disrupts qi transformation, causing internal retention of water and dampness, which further exacerbates deficiency. Throughout history, TCM case studies addressing CFS are not uncommon. Its holistic perspective and syndrome differentiation approach align with CFS’s complex, multi-targeted, and multi-pathway pathology. This study therefore systematically reviews the etiology and pathogenesis of CFS from both TCM and Western medical perspectives, summarizing the applications of both traditional and modern medicine in CFS treatment to provide insights for clinical management and academic research.
Key words
chronic fatigue syndrome
/
traditional Chinese medicine formulas
/
traditional Chinese medicine paste formulas
/
genetic susceptibility
/
pathogen infection
/
gut microbiota imbalance
LI Jixin, WANG Wenru, QIU Linjie, REN Yan, LI Meijie, ZOU Chacha, WU Zijing, WANG Peili, ZHANG Jin.
Advances in traditional Chinese and Western medicine for chronic fatigue syndrome: Theoretical origins, modern mechanisms, and clinical intervention strategies[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(5)
: 1909
-1923
.
DOI: 10.7501/j.issn.0253-2670.2026.05.027
Fukuda K, Straus S E, Hickie I, et al. The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group[J]. Ann Intern Med, 1994, 121(12): 953-959. 黎祖鸣, 封杰妮, 陈雪如, 等. 基于单细胞转录组探讨新型冠状病毒感染后慢性疲劳综合征与炎症反应、氧化应激、细胞凋亡之间分子机制及其潜在干预中药预测[J]. 中草药, 2024, 55(11): 3774-3788. Nacul L, Authier F J, Scheibenbogen C, et al. European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): Expert consensus on the diagnosis, service provision, and care of people with ME/CFS in Europe[J]. Medicina, 2021, 57(5): 510. 郝建梅, 孔莹. 慢性疲劳综合征的病名病机浅析[J]. 陕西中医, 2012, 33(4): 512. 李纪新, 周瑞玲, 黄弘博, 等. 中药及活性成分干预动脉粥样硬化的关键途径: 血管平滑肌细胞增殖、迁移与表型转化[J]. 中国中药杂志, 2025, 50(23): 6583-6597. Fluge Ø, Tronstad K J, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS)[J]. J Clin Invest, 2021, 131(14): e150377. Dibble J J, McGrath S J, Ponting C P. Genetic risk factors of ME/CFS: A critical review[J]. Hum Mol Genet, 2020, 29(R1): R117-R124. Chu L, Valencia I J, Garvert D W, et al. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome[J]. Front Pediatr, 2019, 7: 12. Bested A C, Marshall L M. Review of Myalgic encephalomyelitis/chronic fatigue syndrome: An evidence-based approach to diagnosis and management by clinicians[J]. Rev Environ Health, 2015, 30(4): 223-249. Perez M, Jaundoo R, Hilton K, et al. Genetic predisposition for immune system, hormone, and metabolic dysfunction in myalgic encephalomyelitis/ chronic fatigue syndrome: A pilot study[J]. Front Pediatr, 2019, 7: 206. de Vega W C, Vernon S D, McGowan P O. DNA methylation modifications associated with chronic fatigue syndrome[J]. PLoS One, 2014, 9(8): e104757. Herrera S, de Vega W C, Ashbrook D, et al. Genome-epigenome interactions associated with myalgic encephalomyelitis/chronic fatigue syndrome[J]. Epigenetics, 2018, 13(12): 1174-1190. Carlo-Stella N, Badulli C, De Silvestri A, et al. A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles[J]. Clin Exp Rheumatol, 2006, 24(2): 179-182. Vangeel E, Van Den Eede F, Hompes T, et al. Chronic fatigue syndrome and DNA hypomethylation of the glucocorticoid receptor gene promoter 1F region: Associations with HPA axis hypofunction and childhood trauma[J]. Psychosom Med, 2015, 77(8): 853-862. Tanigawa Y, Li J H, Justesen J M, et al. Components of genetic associations across 2, 138 phenotypes in the UK Biobank highlight adipocyte biology[J]. Nat Commun, 2019, 10(1): 4064. Nunes J M, Kell D B, Pretorius E. Cardiovascular and haematological pathology in myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS): A role for viruses[J]. Blood Rev, 2023, 60: 101075. Liu Z, Hollmann C, Kalanidhi S, et al. Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID[J]. medRxiv, 2023, doi: 10.1101/2023.06.23. 23291827. Blomberg J, Gottfries C G, Elfaitouri A, et al. Infection elicited autoimmunity and myalgic encephalomyelitis/ chronic fatigue syndrome: An explanatory model[J]. Front Immunol, 2018, 9: 229. Banko A, Miljanovic D, Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field[J]. Int J Infect Dis, 2023, 130: 108-125. Ariza M E. Myalgic encephalomyelitis/chronic fatigue syndrome: The human herpesviruses are back![J]. Biomolecules, 2021, 11(2): 185. Alexander J W, Aerni S, Plettner J P. Development of a safe and effective one-minute preoperative skin preparation[J]. Arch Surg, 1985, 120(12): 1357-1361. Kerr J R. The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease[J]. J Clin Pathol, 2016, 69(4): 279-291. Fagundes C P, Glaser R, Alfano C M, et al. Fatigue and herpesvirus latency in women newly diagnosed with breast cancer[J]. Brain Behav Immun, 2012, 26(3): 394-400. Liu T T, Sun W B, Guo S H, et al. Research progress on pathogenesis of chronic fatigue syndrome and treatment of traditional Chinese and Western medicine[J]. Auton Neurosci, 2024, 255: 103198. 王嘉昊, 代茜, 郭宁, 等. 基于肠道菌群探讨从脾胃论治慢性疲劳综合征[J]. 中医药信息, 2024, 41(6): 35-40. Giloteaux L, Goodrich J K, Walters W A, et al. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome[J]. Microbiome, 2016, 4(1): 30. Nagy-Szakal D, Williams B L, Mishra N, et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome[J]. Microbiome, 2017, 5(1): 44. Komaroff A L, Lipkin W I. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome[J]. Trends Mol Med, 2021, 27(9): 895-906. Hornig M, Montoya J G, Klimas N G, et al. Distinct plasma immune signatures in ME/CFS are present early in the course of illness[J]. Sci Adv, 2015, 1(1): e1400121. 李瑞丽, 胡迪, 崔翼龙, 等. 慢性疲劳综合征的神经炎症机制[J]. 国际精神病学杂志, 2020, 47(6): 1113-1117. Montoya J G, Holmes T H, Anderson J N, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients[J]. Proc Natl Acad Sci USA, 2017, 114(34): E7150-E7158. 李纪新, 邱林杰, 任燕, 等. 中药及活性成分靶向M1/M2巨噬细胞极化平衡干预肥胖合并2型糖尿病的研究进展[J]. 中国中药杂志, 2024, 49(13): 3441-3451. 何层层. SLAMF7促进肥胖哮喘小鼠肺组织巨噬细胞M1极化的机制研究[D]. 无锡: 江南大学, 2025. 吴梓敬, 李纪新, 邱林杰, 等. 成人代谢健康型肥胖与炎症因子关系的Meta分析[J]. 武警医学, 2025, 36(5): 426-434. 武筱林. 滋肾活络方干预巨噬细胞极化调节miR-182/ TCF7L2改善高血压心肌重塑机制研究[D]. 济南: 山东中医药大学, 2025. Paul B D, Lemle M D, Komaroff A L, et al. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome[J]. Proc Natl Acad Sci USA, 2021, 118(34): e2024358118. Maes M, Kubera M, Uytterhoeven M, et al. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)[J]. Med Sci Monit, 2011, 17(4): SC11-SC15. Kennedy G, Spence V A, McLaren M, et al. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms[J]. Free Radic Biol Med, 2005, 39(5): 584-589. Sabioni P, Le Foll B. Psychosocial and pharmacological interventions for the treatment of cannabis use disorder[J]. Focus, 2019, 17(2): 163-168. Jammes Y, Steinberg J G, Olivier M, et al. The mechanisms of the widespread production of phosphorylated HSP25 after fatiguing muscle stimulation[J]. J Exp Biol, 2013, 216(Pt19): 3620-3626. Whitham M, Fortes M B. Heat shock protein 72: Release and biological significance during exercise[J]. Front Biosci, 2008, 13: 1328-1339. 王文茹, 王新慧, 闫蕾, 等. 中医药干预糖尿病肾脏疾病的潜在途径: 巨噬细胞极化[J]. 中国中药杂志, 2024, 49(15): 4044-4053. Jammes Y, Steinberg J G, Delliaux S, et al. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and HSP responses[J]. J Intern Med, 2009, 266(2): 196-206. Jammes Y, Steinberg J G, Delliaux S. Chronic fatigue syndrome: Acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins[J]. J Intern Med, 2012, 272(1): 74-84. 张琳, 马巧琳, 于冬冬, 等. 基于线粒体代谢的针灸治疗慢性疲劳综合征的研究进展[J]. 环球中医药, 2024, 17(6): 1199-1204. Pintos-Pascual I, Moreno-Torres V, Ibánez-Estéllez F, et al. Is SARS-CoV-2 the only cause of long-COVID?[J]. AIDS Rev, 2022, 24(4): 183-196. Thapaliya K, Marshall-Gradisnik S, Barth M, et al. Brainstem volume changes in myalgic encephalomyelitis/chronic fatigue syndrome and long COVID patients[J]. Front Neurosci, 2023, 17: 1125208. Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways[J]. Metab Brain Dis, 2014, 29(1): 19-36. Germain A, Ruppert D, Levine S M, et al. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology[J]. Metabolites, 2018, 8(4): 90. Germain A, Ruppert D, Levine S M, et al. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism[J]. Mol Biosyst, 2017, 13(2): 371-379. Annesley S J, Fisher P R. Mitochondria in health and disease[J]. Cells, 2019, 8(7): 680. Komaroff A L, Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome?[J]. Front Med, 2021, 7: 606824. 张思宁, 刘溦溦, 韩秀珍, 等. 基于“脾-线粒体”相关从脾论治慢性疲劳综合征[J]. 世界中医药, 2025, 20(6): 1004-1010. 刘洋, 彭玉清, 葛辛, 等. 健脾益肾法对慢性疲劳综合征患者自由基代谢的影响[J]. 北京中医药, 2019, 38(2): 140-142. 牛占忠, 刘丁丁, 岳雁, 等. 补肾疏肝汤对慢性疲劳综合征大鼠模型抗疲劳作用机制的实验研究[J]. 河北中医, 2020, 42(1): 96-100. 张二伟, 黄琼, 吴同伟, 等. 论慢性疲劳综合征与五脏相关[J]. 世界中西医结合杂志, 2020, 15(4): 763-766. 谭丽, 冯兴中. 基于“虚气流滞”探析慢性疲劳综合征中医病机及治法[J]. 环球中医药, 2021, 14(10): 1801-1804. 卢秋玉, 刘金花, 宾彬, 等. 参杞强精颗粒对慢性疲劳综合征脾肾阳虚证大鼠免疫调节作用研究[J]. 世界中医药, 2024, 19(7): 969-974. 饶晓金, 王英. 基于肠道菌群探析健脾祛湿法治疗“肥人不孕”的作用机制[J]. 中国当代医药, 2025, 32(35): 99-102. 马巧琳, 范宣强, 胡斌, 等.“五神针”对慢性疲劳大鼠线粒体自噬相关信号通路的影响[J]. 世界科学技术—中医药现代化, 2025, 27(4): 992-999. 杨芳明, 肖准, 陈晓琦, 等. 基于脂质代谢异常探讨“痰浊”理论在肝细胞癌微环境中的生物学内涵[J]. 临床肝胆病杂志, 2023, 39(2): 432-438. 冀虹晓, 秦培洁, 王柳青, 等. 从“虚、痰、瘀、毒”探讨冠心病的病机[J]. 中国医药导报, 2024, 21(29): 153-156. 贾昕怡, 邹璐, 方泓. 痰瘀互结证动物模型的建立及评价方法评述[J]. 上海中医药杂志, 2025, 59(5): 95-100. Chen R, Moriya J, Yamakawa J I, et al. Traditional Chinese medicine for chronic fatigue syndrome[J]. Evid Based Complement Alternat Med, 2010, 7(1): 3-10. Li Y X, Yang J Y, Chau C I, et al. Is there a role for traditional and complementary medicines in managing chronic fatigue? A systematic review of randomized controlled trials[J]. Front Pharmacol, 2023, 14: 1266803. 杨书贤, 洪禹, 曹丽娟. 癌因性疲乏发病机制及中医药干预研究进展[J]. 南京中医药大学学报, 2025, 41(6): 838-846. 张禹杰, 方淑蓓, 岑俊, 等. 中医药治疗肌少症的临床应用及治疗机制初探[J]. 上海中医药杂志, 2022, 56(12): 16-22. 石英贤, 李硕, 黄雨龙, 等. 菊苣多糖对低压低氧暴露小鼠的抗疲劳作用及机制[J]. 中国药理学与毒理学杂志, 2025, 39(10): 742-750. 董谷雨, 于杰, 赵鲁南. 枸杞多糖干预大负荷运动大鼠骨骼肌线粒体和抗氧化酶的效应[J]. 中国组织工程研究, 2025, 29(24): 5134-5139. 程艺, 张彦昀, 黄婷, 等. 党参多糖对运动力竭小鼠疲劳的影响[J]. 中国老年学杂志, 2021, 41(16): 3498-3501. 娄旭佳, 阮蓉, 金其贯, 等. 白藜芦醇干预运动性疲劳模型大鼠线粒体动力学的变化[J]. 中国组织工程研究, 2023, 27(17): 2625-2630. 蔡浩刚, 张琳. 红景天苷对运动性疲劳大鼠糖脂代谢和氧化应激的影响[J]. 分子植物育种, 2023, 21(12): 4116-4123. 张震, 朱天宇. 山柰酚抗运动性疲劳的作用研究[J]. 中国临床药理学杂志, 2024, 40(9): 1306-1310. 王静. 荷花活性成分荷叶碱缓解运动性疲劳大鼠脑组织氧化应激与神经炎症的效果[J]. 分子植物育种, 2025, 23(18): 6243-6251. 于继洋. 葡萄柚来源柚皮素缓解运动性疲劳认知障碍的作用机制研究[J]. 分子植物育种, 2025, 23(18): 6209-6216. 杨宝强. 穿心莲丁素的抗疲劳及免疫调节作用[J]. 分子植物育种, 2023, 21(12): 4101-4108. 闫冬, 储金林, 马睿瑶, 等. 胡芦巴总皂苷对小鼠抗疲劳功能的研究[J]. 中国临床药理学杂志, 2022, 38(9): 974-978. 高修鹏, 张永智, 陈宏志. 绞股蓝总皂苷调控HIF-1α/ BNIP3通路改善力竭训练大鼠运动性疲劳的作用机制[J]. 天津师范大学学报: 自然科学版, 2025, 45(3): 28-34. 王建永. 牡蛎多肽对运动疲劳大鼠骨骼肌线粒体功能的影响[J]. 安徽大学学报: 自然科学版, 2020, 44(5): 93-99. Ye J, Shen C H, Huang Y Y, et al. Anti-fatigue activity of sea cucumber peptides prepared from Stichopus japonicus in an endurance swimming rat model[J]. J Sci Food Agric, 2017, 97(13): 4548-4556. 王光元, 马博威. 异甘草素对小鼠运动性疲劳和氧化应激能力的影响[J]. 中国临床药理学杂志, 2024, 40(14): 2103-2107. 蓝瑞高, 梁益军. 人参皂苷CK对力竭游泳大鼠抗疲劳作用及骨骼肌氧化应激的影响[J]. 云南农业大学学报: 自然科学, 2022, 37(3): 491-496. 秦璐. 木犀草苷对运动性疲劳大鼠的心肌氧化应激及抗氧化基因表达的影响[J]. 分子植物育种, 2023, 21(9): 2900-2907. 唐琨洋, 萧闵, 江晓翠, 等. 淫羊藿苷通过RGN改善运动性疲劳模型小鼠精子发生的作用及机制[J/OL]. 中国实验方剂学杂志, (2025-09-11)[2026-02-04]. https://doi.org/10.13422/j.cnki.syfjx.20251744. 宋琦, 高强. 野茼蒿提取物对CFS大鼠抗疲劳、运动行为能力和免疫力的影响[J]. 分子植物育种, 2023, 21(10): 3433-3438. 王猛, 颜克亮, 杨莹, 等. 东紫苏提取物抗疲劳及抗氧化作用的研究[J]. 世界科学技术—中医药现代化, 2020, 22(5): 1641-1647. 李宇. 冬虫夏草抗运动性疲劳和增强运动能力的应用[J]. 中国食用菌, 2020, 39(1): 35-37. 程耀明. 姜黄提取物对运动小鼠生理疲劳和生理机能的影响[J]. 基因组学与应用生物学, 2019, 38(12): 5738-5743. 毛佳音, 郭静妍, 钟玉滢, 等. 黄精水提物对运动性疲劳小鼠的改善作用及机制研究[J/OL]. 中国中药杂志, (2025-11-10)[2026-02-04]. https://doi.org/10.19540/j. cnki.cjcmm.20250915.801. 王莹, 张研, 徐立军, 等. 基于网络药理学和代谢组学研究红景天抗运动性疲劳的作用机制[J]. 食品工业科技, 2026, 47(2): 419-428. 裴科, 林喆, 刘萌萌, 等. 基于网络药理学探讨哈蟆油改善慢性疲劳综合征的作用机制[J/OL]. 食品工业科技, (2025-07-02)[2026-02-04]. https://doi.org/10.13386/ j.issn1002-0306.2025020168. 崔恺, 管雅琪, 张钊, 等. 潞党参通过PI3K/Akt/ GSK3β通路缓解运动性疲劳的作用机制研究[J]. 中药材, 2022, 45(10): 2471-2475. 何芳芳, 刘玲玲, 丁秦怡, 等. 归脾汤加减对心脾两虚型慢性疲劳综合征病人的临床效果分析[J]. 内蒙古中医药, 2024, 43(12): 72. 钱蓉蓉, 朱云飞. 归脾汤治疗慢性疲劳综合征失眠心脾两虚证临床研究[J]. 光明中医, 2024, 39(15): 2975-2978. 潘泗红, 张振贤. 四君子汤治疗脾虚型慢性疲劳综合征临床研究[J]. 新中医, 2024, 56(6): 23-28. 胡明林. 陈宝贵教授治疗慢性疲劳综合征的组方思路探析及临床观察[D]. 天津: 天津中医药大学, 2023. 江旭君. 补中益气汤合小柴胡汤治疗慢性疲劳综合征临床观察[J]. 光明中医, 2023, 38(13): 2540-2542. 臧大伟, 郑连文, 杨子朝, 等. 黑茸胶囊治疗慢性疲劳综合征的临床疗效[J]. 吉林医学, 2023, 44(5): 1253-1256. 李献华, 李明, 陈钦甫, 等. 瓜参汤治疗气阴两虚型慢性疲劳综合征临床疗效观察[J]. 中医药临床杂志, 2022, 34(7): 1331-1335. 盛昭园, 沈洁, 陈园园, 等. 温肾理疲方治疗脾肾阳虚型慢性疲劳综合征的临床疗效观察及对细胞免疫的影响[J]. 中国中医药科技, 2022, 29(2): 228-230. 周妍, 李光, 赵冬丽, 等. 郎宜男经验方治疗脾虚湿困型慢性疲劳综合征的临床观察[J]. 中国民间疗法, 2021, 29(21): 71-73. 刘杰, 胡粤杭, 应汝炯, 等. 柴胡桂枝汤治疗慢性疲劳综合征的临床疗效及情志因素对病情的影响[J]. 世界中西医结合杂志, 2021, 16(10): 1908-1911. 杨梦. “肝肾脾胃养护法”治疗湿热内蕴型慢性疲劳综合征临床研究[D]. 广州: 广州中医药大学, 2021. 郑浪花, 麦杰, 刘映霞. 疏肝健脾益肾方治疗慢性疲劳综合征临床研究[J]. 山东中医杂志, 2017, 36(10): 860-862. 孙宏建, 郭燕洁, 孙小涵, 等. 疏肝益阳胶囊治疗慢性疲劳综合征临床研究[J]. 中医学报, 2016, 31(2): 272-274. 刘亚光. 升阳益胃汤治疗慢性疲劳综合征(脾胃气虚型)的临床研究[D]. 郑州: 河南中医学院, 2015. 王雪. 黄芪建中汤加味治疗慢性疲劳综合征(心脾两虚型)的临床观察[D]. 成都: 成都中医药大学, 2015. 黄帅立, 龙艳, 赵燕. 健脾固肾膏治疗气虚质慢性疲劳综合征临床研究[J]. 新中医, 2024, 56(23): 30-34. 邵彩芬, 张鹏宙. 九味头膏治疗晚期肺癌癌因性疲乏患者临床观察[J]. 浙江中医杂志, 2023, 58(8): 597. 韦正红, 张展洁, 俞树瀚, 等. 九味头膏治疗气血两虚型慢性疲劳综合征189例临床观察[J]. 浙江中医杂志, 2020, 55(12): 880. 杨飞霞, 王玉, 夏鹏飞, 等. 当归补血汤化学成分、药理作用、临床应用的研究进展及质量标志物的预测分析[J]. 中国中药杂志, 2021, 46(11): 2677-2685. 李可. 李可老中医急危重症疑难病经验专辑[M]. 太原: 山西科学技术出版社, 2001: 95-97. 杜远. 自拟益肾补血膏治疗慢性疲劳综合征的临床观察[J]. 光明中医, 2018, 33(22): 3295-3297. 黄丹旋, 黎焕杰, 陈珏璇, 等. 健脾养胃膏方治疗气虚质慢性疲劳综合征临床观察[J]. 中华中医药杂志, 2020, 35(12): 6440-6443. 李静, 陈晓东, 黄惠琼, 等. 健脑益智膏治疗心肾不交、气血不足型慢性疲劳综合征的临床疗效研究[J]. 中医临床研究, 2021, 13(17): 130-133. 张万年. 益气安神膏治疗气血两虚型慢性疲劳综合征的临床研究[D]. 广州: 广州中医药大学, 2018. 王思琦. 内服“慢疲康”膏方与穴位敷贴治疗慢性疲劳综合征的临床对照研究[D]. 广州: 广州中医药大学, 2013. 卫蓉, 潘定举, 刘倩, 等. 龙膏调治男子慢性疲劳综合征(肝肾亏虚型) 30例临床疗效观察[J]. 贵阳中医学院学报, 2017, 39(5): 56-58. 刘爱霞, 王雅娟, 丁梅, 等. 健脾解郁消疲膏治疗青年慢性疲劳综合征40例临床观察[J]. 河北中医, 2014, 36(11): 1625-1626. 冉俊宁, 罗同由, 许华峰, 等. 基于中医体质学的腧穴配伍治疗慢性疲劳综合征的临床观察[J]. 中医药临床杂志, 2024, 36(8): 1599-1603. 郑佳, 陈晓瑜, 李美红, 等. 坤载针灸对慢性疲劳综合征患者生活质量影响的临床观察[J]. 湖南中医杂志, 2024, 40(7): 74-77. 彭文. 调神培本针法治疗慢性疲劳综合征的临床疗效观察[D]. 合肥: 安徽中医药大学, 2024. 黄泽鑫. 普通针刺法治疗慢性疲劳综合征(亚健康态)临床疗效及对血清ACTH、COR、NPY水平影响[D]. 成都: 成都中医药大学, 2024. 陈日新. 热敏灸: 中医灸法的传承、创新与发展[J]. 中国针灸, 2023, 43(4): 483-488. 杨萍, 冼卓妍, 曹淑华. 热敏灸治疗脾气虚弱型慢性疲劳综合征临床研究[J]. 新中医, 2025, 57(1): 110-114. 贾汐沛. 热敏灸五脏俞治疗气虚质慢性疲劳综合征临床观察[D]. 广州: 广州中医药大学, 2023. 林玉芳, 金肖青, 诸剑芳, 等. 隔姜灸治疗慢性疲劳综合征及对患者肠道菌群的影响[J]. 中国针灸, 2021, 41(3): 269-274. 庞宇舟, 李伟伟. 壮医内儿科学[M]. 北京: 中国中医药出版社, 2018. 王成龙, 李燕萍, 谭丽影, 等. 壮医龙脊灸治疗嘘内(慢性疲劳综合征)临床观察[J]. 中国中医药现代远程教育, 2024, 22(17): 123-125. 吴双韵, 付勇, 刘慧, 等. 芳香推拿治疗慢性疲劳综合征34例随机对照临床研究[J]. 中医杂志, 2024, 65(12): 1249-1254. 雷伟, 吕家和. 捏脊振腹法治疗慢性疲劳综合征30例临床观察[J]. 湖南中医杂志, 2023, 39(7): 79-81. 郝佳. 背部推拿法治疗慢性疲劳综合征(脾肾阳虚型)的临床研究[D]. 长春: 长春中医药大学, 2023. Kim D Y, Lee J S, Park S Y, et al. Systematic review of randomized controlled trials for chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME)[J]. J Transl Med, 2020, 18(1): 7. Hickie I B, Wilson A J, Wright J M, et al. A randomized, double-blind placebo-controlled trial of moclobemide in patients with chronic fatigue syndrome[J]. J Clin Psychiatry, 2000, 61(9): 643-648. Blockmans D, Persoons P, Van Houdenhove B, et al. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?[J]. Am J Med, 2006, 119(2): 167.e23-167.e30. Hermans L, Nijs J, Calders P, et al. Influence of morphine and naloxone on pain modulation in rheumatoid arthritis, chronic fatigue syndrome/fibromyalgia, and controls: A double-blind, randomized, placebo-controlled, cross-over study[J]. Pain Pract, 2018, 18(4): 418-430. Boomershine C S. Pregabalin for the management of fibromyalgia syndrome[J]. J Pain Res, 2010, 3: 81-88. Zarling J M, Schlais J, Eskra L, et al. Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues[J]. J Immunol, 1980, 124(4): 1852-1857. Cabanas H, Muraki K, Staines D, et al. Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic encephalomyelitis/chronic fatigue syndrome patients[J]. Front Immunol, 2019, 10: 2545. Adamson J, Ali S, Santhouse A, et al. Cognitive behavioural therapy for chronic fatigue and chronic fatigue syndrome: Outcomes from a specialist clinic in the UK[J]. J R Soc Med, 2020, 113(10): 394-402. Geraghty K J, Blease C. Cognitive behavioural therapy in the treatment of chronic fatigue syndrome: A narrative review on efficacy and informed consent[J]. J Health Psychol, 2018, 23(1): 127-138. Vink M, Vink-Niese A. The draft updated NICE guidance for ME/CFS highlights the unreliability of subjective outcome measures in non-blinded trials[J]. J Health Psychol, 2022, 27(1): 9-12. Clark L V, Pesola F, Thomas J M, et al. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): A pragmatic randomised controlled trial[J]. Lancet, 2017, 390(10092): 363-373. Larun L, Brurberg K G, Odgaard-Jensen J, et al. Exercise therapy for chronic fatigue syndrome[J]. Cochrane Database Syst Rev, 2017, 4(4): CD003200. Bjørkum T, Wang C E A, Waterloo K. Patients' experience with treatment of chronic fatigue syndrome[J]. Tidsskr Nor Laegeforen, 2009, 129(12): 1214-1216. Tuller D, Vink M. Graded exercise therapy and cognitive behavior therapy do not improve employment outcomes in ME/CFS[J]. Work, 2023, 74(4): 1235-1239. White P D, Goldsmith K A, Johnson A L, et al. Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): A randomised trial[J]. Lancet, 2011, 377(9768): 823-836.
PDF下载
全屏
26
8
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
